Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharmarise Holdings Corp. ( (JP:2796) ) has issued an update.
Pharmarise Holdings Corporation reported a significant increase in net sales for the first nine months of the fiscal year ending May 31, 2025, with a 14.5% year-on-year growth. However, the company faced challenges with a substantial decline in operating profit and a net loss attributable to the owners, indicating potential operational difficulties. The financial results reflect a complex market environment, and the company has made changes in accounting policies and added a new company to its consolidation scope, which may impact future performance.
More about Pharmarise Holdings Corp.
Pharmarise Holdings Corporation operates in the pharmaceutical industry, focusing on the development and distribution of healthcare products. The company is listed on the Tokyo Stock Exchange and aims to enhance its market presence through strategic initiatives.
YTD Price Performance: -8.70%
Average Trading Volume: 19,842
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen5.68B
For detailed information about 2796 stock, go to TipRanks’ Stock Analysis page.